Showing results (1661-1670 of 3,660) with videos related to

Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|December 18, 2024
Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten yearsFrederik K Palshof, Lina S Mørch, Maj-Britt R Jensen, et al.
Breast (Edinburgh, Scotland)|December 21, 2024
Breast cancer patients with a pre-existing mental illness are less likely to receive guideline-recommended cancer treatment: A systematic review and meta-analysisKatie Elliott, Emily Haworth, Iakov Bolnykh, et al.
Breast (Edinburgh, Scotland)|December 15, 2024
Novel models based on machine learning to predict the prognosis of metaplastic breast cancerYinghui Zhang, Wenxin An, Cong Wang, et al.
Breast (Edinburgh, Scotland)|January 3, 2025
The impact on productivity costs of reducing unemployment in patients with advanced breast cancer: A model estimation based on a Portuguese nationwide observational studyLeonor Vasconcelos de Matos, Margarida Borges, Ana Teresa Oliveira, et al.
Breast (Edinburgh, Scotland)|February 21, 2025
Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil's public and private healthcare systemsMarcelo Antonini, André Mattar, Denise Joffily Pereira da Costa Pinheiro, et al.
Breast (Edinburgh, Scotland)|February 23, 2025
Diagnostic delay in women with cancer: What do we know and which factors contribute?Liza A Hoveling, Melinda Schuurman, Sabine Siesling, et al.
Breast (Edinburgh, Scotland)|February 25, 2025
Comprehensive genomic profiling can predict response to neoadjuvant chemotherapy in triple-negative breast cancerMonika Drobniene, Dominyka Breimelyte, Ieva Sadzeviciene, et al.
Breast (Edinburgh, Scotland)|January 14, 2025
Retrospective comparative survival analysis of ablation plus systemic therapy versus systemic therapy alone for breast cancer liver metastases, stratified by extrahepatic metastases statusXuxiazi Zou, Hong-Liang Zou, Xuan Luo, et al.
Breast (Edinburgh, Scotland)|January 4, 2025
Clinical treatment score Post-5 Years (CTS5) predicts the benefit of postmastectomy radiotherapy in patients with T1-2N1 luminal breast cancerKe Liu, Guan-Qiao Li, Si-Qi Li, et al.
Breast (Edinburgh, Scotland)|March 22, 2025
Prognostic factors and treatment insights for metastatic malignant phyllode tumorsMengjia Han, Yunyi Zhang, Rong Lei, et al.
Pageof 366